The miR-100-5p Targets SMARCA5 to Regulate the Apoptosis and Intracellular Survival of BCG in Infected THP-1 Cells

Li Su, Tingting Zhu, Han Liu, Yifan Zhu, Yongchong Peng, Tian Tang, Shiying Zhou, Changmin Hu, Huanchun Chen, Aizhen Guo, Yingyu ChenCells 2023 · DOI

TL;DR

This study reveals a novel mechanism by which the host cell microRNA miR-100-5p helps fight Mycobacterium tuberculosis (M.tb) infection. By targeting SMARCA5, miR-100-5p promotes macrophage apoptosis, leading to reduced bacterial survival. This discovery opens avenues for host-directed therapies against TB.

What Problem Does This Paper Address?

Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb), remains a major global health threat, leading to millions of deaths annually. While the immune system, particularly macrophages, attempts to clear M.tb, the pathogen is adept at evading these defenses and establishing persistent infections. MicroRNAs (miRNAs), small non-coding RNA molecules that regulate gene expression, are known to play roles in M.tb infection, but the specific function of miR-100-5p in this context was largely unknown. This paper aims to elucidate the role of miR-100-5p in macrophage response to M.tb infection, specifically focusing on how it influences bacterial survival and host cell apoptosis.

Methods

The researchers employed a multi-pronged approach to investigate miR-100-5p's function:

  • Cell Culture and Infection: Human monocytic leukemia cells (THP-1) were used as a model macrophage system and infected with Mycobacterium bovis BCG (a weakened strain of M.tb often used in research).
  • miRNA and Gene Expression Analysis: Quantitative Real-Time PCR (qRT-PCR) and RNA sequencing (RNA-seq) were used to measure the expression levels of miR-100-5p and its potential target genes.
  • miRNA Manipulation: THP-1 cells were transfected with miR-100-5p mimics (to increase its levels) or inhibitors (to decrease its levels) to study the effects of altering its expression. Small interfering RNAs (siRNAs) were used to silence the expression of the target gene, SMARCA5.
  • Apoptosis Assays: Lactate dehydrogenase (LDH) release assay and Annexin V/Propidium Iodide (PI) staining followed by flow cytometry were used to quantify cell death and apoptosis. Western blotting was employed to assess the expression of key apoptosis-related proteins like Caspase-3 and Bcl-2.
  • Signaling Pathway Analysis: Western blotting was used to examine the phosphorylation status of proteins in the PI3K/AKT pathway, a crucial pathway involved in cell survival and apoptosis.
  • Intracellular Bacterial Survival Assay: Colony-forming unit (CFU) counts were performed on lysed infected cells to quantify the number of viable intracellular bacteria.
  • Target Gene Validation: Dual-luciferase reporter assays were conducted in HEK 293T cells to confirm direct binding of miR-100-5p to the 3'-untranslated region (UTR) of its predicted target gene, SMARCA5.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • BCG infection suppresses a key host defense miRNA: A surprising finding is that BCG infection significantly decreases the expression of miR-100-5p in macrophages. This suggests the bacteria actively work to suppress host defense mechanisms.
  • miR-100-5p acts as a pro-apoptotic factor against BCG: When miR-100-5p levels are artificially increased, it leads to increased apoptosis in infected macrophages. Conversely, inhibiting miR-100-5p reduces apoptosis. This highlights its role in promoting host cell death to eliminate the pathogen.
  • SMARCA5 is a direct target of miR-100-5p: The study provides strong evidence that SMARCA5 is a direct target of miR-100-5p. This is a crucial link, as SMARCA5 is known to be involved in chromatin remodeling and has been implicated in cell survival.
  • The miR-100-5p/SMARCA5 axis impacts the PI3K/AKT pathway: The research demonstrates that miR-100-5p, by targeting SMARCA5, influences the PI3K/AKT signaling pathway, which is critical for cell survival. Upregulating miR-100-5p appears to promote PI3K/AKT activation, which paradoxically, in this context, leads to apoptosis. This suggests a complex interplay where SMARCA5 might normally suppress apoptosis, and miR-100-5p's inhibition of SMARCA5 releases this suppression.
  • Reduced apoptosis leads to increased bacterial survival: When miR-100-5p is inhibited (leading to less apoptosis), or when SMARCA5 is silenced (which would normally promote apoptosis), the survival of intracellular BCG is significantly enhanced. This directly links the miR-100-5p/SMARCA5 pathway to the control of bacterial load.

Key Results

  • BCG infection led to a significant downregulation of miR-100-5p in THP-1 cells.
  • Overexpression of miR-100-5p promoted apoptosis in BCG-infected THP-1 cells, evidenced by increased Caspase-3 and decreased Bcl-2 expression.
  • Inhibition of miR-100-5p led to decreased apoptosis and increased intracellular BCG survival.
  • SMARCA5 was identified as a direct target of miR-100-5p, with miR-100-5p mimic reducing SMARCA5 expression and miR-100-5p inhibitor increasing it.
  • The miR-100-5p mimic promoted phosphorylation of AKT and PI3K, while the inhibitor repressed it.
  • Silencing SMARCA5 partially rescued the anti-apoptotic effect of miR-100-5p inhibition, suggesting SMARCA5 is a key mediator.
  • Ultimately, miR-100-5p overexpression led to reduced intracellular BCG survival, while its inhibition increased survival.

Limitations and Future Work

  • Mechanism of PI3K/AKT regulation: While the study shows miR-100-5p influences the PI3K/AKT pathway, the precise molecular details of how SMARCA5 mediates this effect and how it ultimately leads to apoptosis remain unclear and warrant further investigation.
  • Downregulation mechanism: The exact reasons for miR-100-5p downregulation during BCG infection are not fully elucidated and are suggested for future exploration.
  • In vivo relevance: The study was conducted using an in vitro model (THP-1 cells). Future work should focus on validating these findings in animal models and human clinical samples to confirm their relevance to actual TB pathogenesis.
  • Therapeutic potential: The authors suggest that miR-100-5p could be a target for host-directed anti-TB therapies, but further research is needed to develop effective delivery strategies and assess safety and efficacy.

Summary updated

Abstract

<i>Mycobacterium tuberculosis</i> (<i>M. tb</i>) is the causative agent of tuberculosis (TB) that leads to millions of deaths each year. Extensive evidence has explored the involvement of microRNAs (miRNAs) in <i>M. tb</i> infection. Limitedly, the concrete function of microRNA-100-5p (miR-100-5p) in <i>M. tb</i> remains unexplored and largely elusive. In this study, using Bacillus Calmette-Guérin (BCG) as the model strain, we validated that miR-100-5p was significantly decreased in BCG-infected THP-1 cells. miR-100-5p inhibition effectively facilitated the apoptosis of infected THP-1 cells and reduced BCG survival by regulating the phosphatidylinositol 3-kinase/AKT pathway. Further, SMARCA5 was the target of miR-100-5p and reduced after miR-100-5p overexpression. Since BCG infection down-regulated miR-100-5p in THP-1 cells, the SMARCA5 expression was up-regulated, which in turn increased apoptosis through caspase-3 and Bcl-2 and, thereby, reducing BCG intracellular survival. Collectively, the study uncovered a new molecular mechanism of macrophage to suppress mycobacterial infection through miR-100-5p and SMARCA5 pathway.
BibTeX
@inproceedings{su2023mir,
  author = {Li Su and Tingting Zhu and Han Liu and Yifan Zhu and Yongchong Peng and Tian Tang and Shiying Zhou and Changmin Hu and Huanchun Chen and Aizhen Guo and Yingyu Chen},
  title = {{The miR-100-5p Targets SMARCA5 to Regulate the Apoptosis and Intracellular Survival of BCG in Infected THP-1 Cells}},
  booktitle = {Cells},
  year = {2023},
  doi = {10.3390/cells12030476},
}
Figure